Efficacy of Memantine Added to Cholinesterase Inhibitors on SIB Higher-Order Cognitive Domains: Pooled Post Hoc Analysis of 2 Randomized Controlled Trials in Patients With Moderate to Severe AD

被引：0
|
作者：
Schmitt, Frederick A. [1 ]
Grossberg, George T. [2 ]
Tariot, Pierre N. [3 ]
Hendrix, Suzanne [4 ]
Ellison, Noel [4 ]
Kerolous, Majid [5 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
[2] St Louis Univ, St Louis, MO 63103 USA
[3] Univ Arizona, Banner Alzheimers Inst, Phoenix, AZ USA
[4] Pentara Corp, Salt Lake City, UT USA
[5] Allergan Plc, Madison, NJ USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.1-007
引用
收藏
页数：3
相关论文
共 42 条
  • [31] Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: a systematic review and network meta-analysis of randomized controlled trials
    Cai, Wenting
    Tong, Rui
    Sun, Yue
    Yao, Yao
    Zhang, Jinping
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] Effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients with moderate to severe chronic kidney disease: Meta-analysis of randomized controlled trials using unadjusted data
    Yang, Man
    Wang, Ling
    Gu, Lijie
    Yuan, Weijie
    JOURNAL OF DIABETES, 2017, 9 (12) : 1107 - 1117
  • [33] Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials
    Greg Fulcher
    Roopa Mehta
    Edmond G. Fita
    Magnus Ekelund
    Stephen C. Bain
    Diabetes Therapy, 2019, 10 : 107 - 118
  • [34] Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials
    Fulcher, Greg
    Mehta, Roopa
    Fita, Edmond G.
    Ekelund, Magnus
    Bain, Stephen C.
    DIABETES THERAPY, 2019, 10 (01) : 107 - 118
  • [35] Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials
    Lange, Bernd
    Sohns, Melanie
    Tempero, Jose
    Elling, Christian
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (12) : 2113 - 2123
  • [36] Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3
    Papp, K. A.
    Gordon, K. B.
    Langley, R. G.
    Lebwohl, M. G.
    Gottlieb, A. B.
    Rastogi, S.
    Pillai, R.
    Israel, R. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (02) : 320 - 328
  • [37] Efficacy of anifrolumab across organ domains in patients with moderate-tosevere systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP- 1 and TULIP-2 trials(Jul, 10.1016/S2665-9913(22)00195-3, 2022)
    Morand, E. F.
    Furie, R. A.
    Bruce, I. N.
    LANCET RHEUMATOLOGY, 2022, 4 (09): : E588 - E588
  • [38] Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies
    Smitherman, Todd A.
    Tietjen, Gretchen E.
    Schuh, Kory
    Skljarevski, Vladimir
    Lipsius, Sarah
    D'Souza, Deborah N.
    Pearlman, Eric M.
    HEADACHE, 2020, 60 (10): : 2202 - 2219
  • [39] Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes MellitusResults of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials
    Peter H. Jones
    Kenneth Cusi
    Michael H. Davidson
    Maureen T. Kelly
    Carolyn M. Setze
    Kamlesh Thakker
    Darryl J. Sleep
    C. Stolzenbach
    American Journal of Cardiovascular Drugs, 2010, 10 : 73 - 84
  • [40] Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials
    Jones, Peter H.
    Cusi, Kenneth
    Davidson, Michael H.
    Kelly, Maureen T.
    Setze, Carolyn M.
    Thakker, Kamlesh
    Sleep, Darryl J.
    Stolzenbach, James C.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (02) : 73 - 84
12345